You are here: All Products  > Akeso Starts China Phase III Trial of PD-1/CTLA-4 Bispecific for NSCLC

Akeso Starts China Phase III Trial of PD-1/CTLA-4 Bispecific for NSCLC

Price: $5.00
Available

Get instant access to this article for unlimited viewing and/or downloading for seven days.


Back to products